Qilu, Lynk Score Phase III Wins In China Cancer, Atopic Dermatitis Trials

 
• By Dexter Jie Yan
  
Many Shots On Target
Qilu and Lynk triumph in Phase III trails of their drug candidates. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D